Health
Clinical Challenges: When to Add Immunotherapy in Breast Cancer – MedPage Today
Immune checkpoint inhibitors and other immunotherapies may soon have an expanded role
For breast cancer patients, the current indications for immune checkpoint inhibitors (ICIs) are generally limited to triple-negative breast cancer (TNBC), both in high-risk early-stage disease or in the advanced setting for tumors with certain levels of…
Continue Reading
-
Noosa News18 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Business19 hours agoASX 200 lifts on the RBA’s latest interest rate call
-
Noosa News22 hours agoNo conviction recorded for teen behind attack on Peter Dutton’s office
-
Business11 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?